WA Kamps

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

VHJ van der Velden, DCH Jacobs, AJM Wijkhuijs et al. · Leukemia · 2002 · 142 citations

Hematological Malignancy, Bone Marrow Failure, Mixed-phenotype Acute Leukemia +10

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group

Andrea Biondi, MG Valsecchi, Taku Seriu et al. · Leukemia · 2000 · 116 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +12

Precursor-B-ALL with DH–JH gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14

Tomasz Szczepański, MJ Willemse, ER van Wering et al. · Leukemia · 2001 · 97 citations

Immunogenetics, Cytogenetics, Immune Cell Development +12

Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.

Jh Degraaf, Ryj Tamminga, WA Kamps et al. · PubMed · 1995 · 50 citations · Full text

DNA ploidy and karyotype in recurrent and metastatic soft tissue sarcomas.

W. M. Molenaar, HJ Hoekstra, WA Kamps et al. · PubMed · 1992 · 31 citations